Gastroretentive drug delivery systems

Bibliography

• MINAMI H, MCCALLUM RW: The physiology and pathophysiology of gastric emptying in humans. Gastroenterology (1984) 86:1592-1610.
   PubMed Web of Science ®Google Scholar
• COUPE AJ, DAVIS SS, EVANS DF, WILDING IR: Do pellet formulations empty from the stomach with food? Int. J. Pharm. (1993) 92:167-175.
   Web of Science ®Google Scholar
• BETEN DB, VAN GANSBEKE B, SCHOUTENS A, MOËS AJ: Evaluation of the gastric behaviour of coevaporate particles under fasting and non-fasting conditions. Int. J. Pharm. (1995) 123:145-147.
   Google Scholar
• ROUGE N, BURI P, DOELKER E: Drug absorption sites in the gastrointestinal tract and dosage forms for site-specific delivery. Int. J. Pharm. (1996) 136:117-139.
   Web of Science ®Google Scholar
• WEITSCHIES W, KOSCH O, MÖNNIKES H, TRAHMS L: Magnetic marker monitoring: An application of biomagnetic measurement instrumentation and principles for the determination of the gastrointestinal behavior of magnetically marked solid dosage forms. Adv. Drug Deliv. Rev. (2005) 57:1210-1222.
   PubMed Web of Science ®Google Scholar
• KHOSLA R, DAVIS SS: The effect of tablet size on the gastric emptying of non-disintegrating tablets. Int. J. Pharm. (1990) 62:R9-R11.
   Web of Science ®Google Scholar
• COUPE AJ, DAVIS SS, EVANS DF, WILDING IR: Correlation of the gastric emptying of nondisintegrating tablets with gastrointestinal motility. Pharm. Res. (1991) 8:1281-1285.
   PubMed Web of Science ®Google Scholar
• BLOK D, ARNDT JW, DE HAAN FH, VERMEIJ P, JUNGINGER HE, PAUWELS EK: Scintigraphic investigation of the gastric emptying of 3 mm pellets in human volunteers. Int. J. Pharm. (1991) 73:171-176.
   Web of Science ®Google Scholar
• TIMMERMANS J, MOËS AJ: Factors controlling the buoyancy and gastric retention capabilities of floating matrix capsules: new data for reconsidering the controversy. J. Pharm. Sci. (1994) 83:18-24.
   PubMed Web of Science ®Google Scholar
• O’REILLY S, WILSON CG, HARDY JG: The influence of food on the gastric emptying of multiparticulate dosage forms. Int. J. Pharm. (1987) 34:213-216.
   Web of Science ®Google Scholar
• SANGEKAR S, VADINO WA, CHAUDRY I, PARR A, BEIHN R, DIGENIS G: Evaluation of the effect of food and specific gravity of tablets on gastric retention time. Int. J. Pharm. (1987) 35:187-191.
   Web of Science ®Google Scholar
• DAVIS SS, KHOSLA R, WILSON CG, WASHINGTON N: Gastrointestinal transit of a controlled-release pellet formulation of tiaprofenic acid and the effect of food. Int. J. Pharm. (1987) 35:253-258.
   Web of Science ®Google Scholar
• KHOSLA R, FEELY LC, DAVIS SS: Gastrointestinal transit of non-disintegrating tablets in fed subjects. Int. J. Pharm. (1989) 53:107-117.
   Web of Science ®Google Scholar
• GRÖNING R, HEUN G: Dosage forms with controlled gastrointestinal passage – studies on the absorption of nitrofurantoin. Int. J. Pharm. (1989) 56:111-116.
   Google Scholar
• WILDING IR, SPARROW RA, DAVIS SS, HORTON RJ: The role of gastric emptying in the absorption and metabolism of nifedipine given in a modified release pellet formulation. Int. J. Pharm. (1992) 84:59-67.
   Web of Science ®Google Scholar
• ABRAHAMSSON B, ALPSTEN M, HUGOSSON M et al.: Absorption, gastrointestinal transit, and tablet erosion of felodipine extended-release (ER) tablets. Pharm. Res. (1993) 10:709-714.
   PubMed Web of Science ®Google Scholar
• KAUS LC, FELL JT, SHARMA H, TAYLOR DC: Gastric emptying and intestinal transit of non-disintegrating capsules – the influence of metoclopramide. Int. J. Pharm. (1984) 22:99-103.
   Web of Science ®Google Scholar
• BENNETT CE, HARDY JG, WILSON CG: The influence of posture on the gastric emptying of antacids. Int. J. Pharm. (1984) 21:341-347.
   Web of Science ®Google Scholar
• MOJAVERIAN P, VLASSES PH, KELLNER PE, ROCCI ML Jr: Effects of gender, posture, and age on gastric residence time of an indigestible solid: pharmaceutical considerations. Pharm. Res. (1988) 5:639-644.
   PubMed Web of Science ®Google Scholar
• COUPE AJ, DAVIS SS, EVANS DF, WILDING IR: The effect of sleep on the gastrointestinal transit of pharmaceutical dosage forms. Int. J. Pharm. (1992) 78:69-76.
   Google Scholar
• COUPE AJ, DAVIS SS, EVANS DF, WILDING IR: Nocturnal scintigraphic imaging to investigate the gastrointestinal transit of dosage forms. J. Control. Release (1992) 20:155-162.
   Web of Science ®Google Scholar
• OTH M, FRANZ M, TIMMERMANS J, MOËS A: The bilayer floating capsule: a stomach-directed drug delivery system for misoprostol. Pharm. Res. (1992) 9:298-302.
   PubMed Web of Science ®Google Scholar
• FÁBREGAS JL, CLARAMUNT J, CUCALA J, POUS R, SILES A: In vitro testing of an antacid formulation with prolonged gastric residence time (Almagate Flot-Coat®). Drug Dev. Ind. Pharm. (1994) 20:1199-1212.
   Web of Science ®Google Scholar
• HILTON AK, DEASY PB: In vitro and in vivo evaluation of an oral sustained-release floating dosage form of amoxycillin trihydrate. Int. J. Pharm. (1992) 86:79-88.
   Web of Science ®Google Scholar
• WHITEHEAD L, FELL JT, COLLETT JH: Development of gastroretentive dosage form. Eur. J. Pharm. Sci. (1996) 4:S182.
   Google Scholar
• WHITEHEAD L, COLLETT JH, FELL JT: Amoxycillin release from a floating dosage form based on alginates. Int. J. Pharm. (2000) 210:45-49.
   PubMed Web of Science ®Google Scholar
• ERNI W, HELD K: The hydrodynamically balanced system: a novel principle of controlled drug release. Eur. Neurol. (1987) 27(Suppl. 1):21-27.
   PubMedGoogle Scholar
• HOFFMAN A, STEPENSKY D, LAVY E, EYAL S, KLAUSNER E, FRIEDMAN M: Pharmacokinetic and pharmacodynamic aspects of gastroretentive dosage forms. Int. J. Pharm. (2004) 277:141-153.
   PubMed Web of Science ®Google Scholar
• ICHIKAWA M, KATO T, KAWAHARA M, WATANABE S, KAYANO M: A new multiple-unit oral floating dosage system. II: In vivo evaluation of floating and sustained-release characteristics with p-aminobenzoic acid and isosorbide dinitrate as model drugs. J. Pharm. Sci. (1991) 80:1153-1156.
   PubMed Web of Science ®Google Scholar
• MENON A, RITSCHEL WA, SAKR A: Development and evaluation of a monolithic floating dosage form for furosemide. J. Pharm. Sci. (1994) 83:239-245.
   PubMed Web of Science ®Google Scholar
• ÖZDEMIR N, ORDU S, ÖZKAN Y: Studies of floating dosage forms of furosemide: in vitro and in vivo evaluations of bilayer tablet formulations. Drug. Dev. Ind. Pharm. (2000) 26:857-866.
   PubMed Web of Science ®Google Scholar
• LEVY G, JUSKO WJ: Factors affecting the absorption of riboflavin in man. J. Pharm. Sci. (1966) 55:285-289.
   PubMed Web of Science ®Google Scholar
• LIPPOLD BC, GÜNTHER J: In vivo Prüfung einer multipartikulären Retard-Schwimmarzneiform. Eur. J. Pharm. Biopharm. (1991) 37:254-261.
   Web of Science ®Google Scholar
• SINGH MATHARU R, SANGHAVI NM: Novel drug delivery system for captopril. Drug Dev. Ind. Pharm. (1992) 18:1567-1574.
   Web of Science ®Google Scholar
• SHETH PR, TOSSOUNIAN J: The hydrodynamically balanced system (HBSTM): A novel drug delivery system for oral use. Drug Dev. Ind. Pharm. (1984) 10:313-339.
   Web of Science ®Google Scholar
• CHEN GL, HAO WH: In vitro performance of floating sustained-release capsule of verapamil. Drug Dev. Ind. Pharm. (1998) 24:1067-1072.
   PubMed Web of Science ®Google Scholar
• SOPPIMATH KS, KULKARNI AR, AMINABHAVI TM: Development of hollow microspheres as floating controlled-release systems for cardiovascular drugs: preparation and release characteristics. Drug Dev. Ind. Pharm. (2001) 27:507-515.
   PubMed Web of Science ®Google Scholar
• ELKHESHEN SA, YASSIN AE, ALSUWAYEH S, ALKHALED FA: In vitro and in vivo evaluation of floating controlled release dosage forms of verapamil hydrochloride. Pharm. Ind. (2004) 66:1364-1372.
   Web of Science ®Google Scholar
• KEDZIEREWICZ F, THOUVENOT P, LEMUT J, ETIENNE A, HOFFMAN M, MAINCENT P: Evaluation of peroral silicone dosage forms in humans by gamma-scintigraphy. J. Control. Release (1999) 58:195-205.
   PubMed Web of Science ®Google Scholar
• MOËS AJ: Gastroretentive dosage forms. Crit. Rev. Therap. Drug Carrier Syst. (1993) 10:143-195.
   PubMed Web of Science ®Google Scholar
• DESHPANDE AA, RHODES CT, SHAH NH, MALICK AW: Controlled-release drug delivery systems for prolonged gastric residence: an overview. Drug Dev. Ind. Pharm. (1996) 22:531-539.
   Web of Science ®Google Scholar
• HWANG SJ, PARK H, PARK K: Gastric retentive drug-delivery systems. Crit. Rev. Therap. Drug Carrier Syst. (1998) 15:243-284.
   PubMed Web of Science ®Google Scholar
• SOPPIMATH KS, KULKARNI AR, RUDZINSKI WE, AMINABHAVI TM: Microspheres as floating drug-delivery systems to increase gastric retention of drugs. Drug Metab. Rev. (2001) 33:149-160.
   PubMed Web of Science ®Google Scholar
• AKIYAMA Y, NAGAHARA N: Novel formulation approaches to oral muco-adhesive drug delivery systems. In: Bioadhesive Drug Delivery Systems – Fundamentals, Novel Approaches and Development. E Mathiowitz, DE Chickering III, CM Lehr (Eds.), Marcel Dekker, New York, NY, USA (1999):477-505.
   Google Scholar
• CHITNIS VS, MALSHE VS, LALLA JK: Bioadhesive polymers – synthesis, evaluation and application in controlled release tablets. Drug Dev. Ind. Pharm. (1991) 17:879-892.
   Web of Science ®Google Scholar
• ROUGE N, ALLÉMANN E, GEX-FABRY M et al.: Comparative pharmacokinetic study of a floating multiple-unit capsule, a high-density multiple-unit capsule and an immediate-release tablet containing 25 mg atenolol. Pharm. Acta Helv. (1998) 73:81-87.
   PubMedGoogle Scholar
• KRÖGEL I, BODMEIER R: Floating or pulsatile drug delivery systems based on coated effervescent cores. Int. J. Pharm. (1999) 187:175-184.
   PubMed Web of Science ®Google Scholar
• PARK K, ROBINSON JR: Bioadhesive polymers as platforms for oral-controlled drug delivery: method to study bioadhesion. Int. J. Pharm. (1984) 19:107-127.
   Web of Science ®Google Scholar
• PEPPAS NA, SAHLIN JJ: Hydrogels as muco-adhesive and bioadhesive materials: a review. Biomaterials (1996) 17:1553-1561.
   PubMed Web of Science ®Google Scholar
• PONCHEL G, IRACHE JM: Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. Adv. Drug Deliv. Rev. (1998) 34:191-219.
   PubMed Web of Science ®Google Scholar
• SINGLA AK, CHAWLA M, SINGH A: Potential applications of Carbomer in oral muco-adhesive controlled drug delivery system: a review. Drug Dev. Ind. Pharm. (2000) 26:913-924.
   PubMed Web of Science ®Google Scholar
• LEE JW, PARK JH, ROBINSON JR: Bioadhesive-based dosage forms: the next generation. J. Pharm. Sci. (2000) 89:850-866.
   PubMed Web of Science ®Google Scholar
• CUÑA M, ALONSO MJ, TORRES D: Preparation and in vivo evaluation of muco-adhesive microparticles containing amoxycillin-resin complexes for drug delivery to the gastric mucosa. Eur. J. Pharm. Biopharm. (2001) 51:199-205.
   PubMed Web of Science ®Google Scholar
• JACKSON SJ, BUSH D, WASHINGTON N, PERKINS AC: Effect of resin surface charge on gastric mucoadhesion and residence of cholestyramine. Int. J. Pharm. (2000) 205:173-181.
   PubMed Web of Science ®Google Scholar
• HEJAZI R, AMIJI M: Stomach-specific anti-H. pylori therapy. I. Preparation and characterization of tetracycline-loaded chitosan microspheres. Int. J. Pharm. (2002) 235:87-94.
   PubMed Web of Science ®Google Scholar
• HEJAZI R, AMIJI M: Stomach-specific anti-H. pylori therapy. II. Gastric residence studies of tetracycline-loaded chitosan microspheres in gerbils. Pharm. Dev. Technol. (2003) 8:253-262.
   PubMed Web of Science ®Google Scholar
• HEJAZI R, AMIJI M: Stomach-specific anti-H. pylori therapy part III: effect of chitosan microspheres crosslinking on the gastric residence and local tetracycline concentrations in fasted gerbils. Int. J. Pharm. (2004) 272:99-108.
   PubMed Web of Science ®Google Scholar
• HIGO S, ORI K, TAKEUCHI H, YAMAMOTO H, HINO T, KAWASHIMA Y: A novel evaluation method of gastric muco-adhesive property in vitro and the muco-adhesive mechanism of tetracycline-sucralfate acidic complex for eradication of Helicobacter pylori. Pharm. Res. (2004) 21:413-419.
   PubMed Web of Science ®Google Scholar
• SCHMITZ T, LEITNER VM, BERNKOP-SCHNÜRCH A: Oral heparin delivery: design and in vivo evaluation of a stomach-targeted muco-adhesive delivery system. J. Pharm. Sci. (2005) 94(5):966-973.
   PubMed Web of Science ®Google Scholar
• KHOSLA R, DAVIS SS: Effect of polycarbophil on the gastric emptying of pellets. J. Pharm. Pharmacol. (1987) 39:47-49.
   PubMed Web of Science ®Google Scholar
• KLAUSNER E, LAVY E, FRIEDMAN M, HOFFMAN A: Expandable gastroretentive dosage forms. J. Control. Release (2003) 90:143-162.
   PubMed Web of Science ®Google Scholar
• CARGILL R, CALDWELL LJ, ENGLE K, FIX JA, PORTER PA, GARDNER CR: Controlled gastric emptying. 1. Effects of physical properties on gastric residence times of nondisintegrating geometric shapes in beagle dogs. Pharm. Res. (1988) 5:533-536.
   PubMed Web of Science ®Google Scholar
• CARGILL R, ENGLE K, GARDNER CR, PORTER P, SPARER RV, FIX JA: Controlled gastric emptying. II. In vitro erosion and gastric residence times of an erodible device in beagle dogs. Pharm. Res. (1989) 6:506-509.
   PubMed Web of Science ®Google Scholar
• FIX JA, CARGILL R, ENGLE K: Controlled gastric emptying. III. Gastric residence time of a nondisintegrating geometric shape in human volunteers. Pharm. Res. (1993) 10:1087-1089.
   PubMed Web of Science ®Google Scholar
• KLAUSNER EA, LAVY E, STEPENSKY D, FRIEDMAN M, HOFFMAN A: Novel gastroretentive dosage forms: evaluation of gastroretentivity and its effect on riboflavin absorption in dogs. Pharm. Res. (2002) 19:1516-1523.
   PubMed Web of Science ®Google Scholar
• KLAUSNER EA, EYAL S, LAVY E, FRIEDMAN M, HOFFMAN A: Novel levodopa gastroretentive dosage form: in vivo evaluation in dogs. J. Control. Release (2003) 88:117-126.
   PubMed Web of Science ®Google Scholar
• KLAUSNER EA, LAVY E, BARTA M, CSEREPES E, FRIEDMAN M, HOFFMAN A: Novel gastroretentive dosage forms: evaluation of gastroretentivity and its effect on levodopa absorption in humans. Pharm. Res. (2003) 20:1466-1473.
   PubMed Web of Science ®Google Scholar
• DESHPANDE AA, SHAH NH, RHODES CT, MALICK W: Development of a novel controlled-release system for gastric retention. Pharm. Res. (1997) 14:815-819.
   PubMed Web of Science ®Google Scholar
• DESHPANDE AA, SHAH NH, RHODES CT, MALICK W: Evaluation of films used in development of a novel controlled-release system for gastric retention. Int. J. Pharm. (1997) 159:255-258.
   Web of Science ®Google Scholar
• CLOER C, GRÖNING R: Development of novel controlled-release dosage forms for gastric retention based on expandable sponges. Proceedings of the 3rd World Meeting APV/APGI. Berlin, Germany (2000):255-256.
   Google Scholar
• SHALABY WS, PARK K: Biochemical and mechanical characterization of enzyme-digestible hydrogels. Pharm. Res. (1990) 7:816-823.
   PubMed Web of Science ®Google Scholar
• SHALABY WS, BLEVINS WE, PARK K: Gastric retention of enzyme-digestible hydrogels in the canine stomach under fasted and fed conditions. In: Polymeric Drugs and Drug Delivery Systems. RL Dunn, RM Ottenbrite (Eds.), ACS Symposium Series, Washington, WA, USA (1991):237-248.
   Google Scholar
• SHALABY WS, BLEVINS WE, PARK K: In vitro and in vivo studies of enzyme-digestible hydrogels for oral drug delivery. J. Control. Release (1992) 19:131-144.
   Google Scholar
• CHEN J, PARK H, PARK K: Synthesis of superporous hydrogels: hydrogels with fast swelling and superabsorbent properties. J. Biomed. Mater. Res. (1999) 44:53-62.
   PubMed Web of Science ®Google Scholar
• CHEN J, PARK K: Synthesis of fast-swelling, superporous sucrose hydrogels. Carbohydrate Polymers (2000) 41:259-268.
   Web of Science ®Google Scholar
• CHEN J, BLEVINS WE, PARK H, PARK K: Gastric retention properties of superporous hydrogel composites. J. Control. Release (2000) 64:39-51.
   PubMed Web of Science ®Google Scholar
• CHEN J, PARK K: Synthesis and characterization of superporous hydrogel composites. J. Control. Release (2000) 65:73-82.
   PubMed Web of Science ®Google Scholar
• OMIDIAN H, ROCCA JG, PARK K: Advances in superporous hydrogels. J. Control. Release (2005) 102:3-12.
   PubMed Web of Science ®Google Scholar
• GUPTA PK, ROBINSON JR: Effect of volume and viscosity of coadministered fluid on gastrointestinal distribution of small particles. Int. J. Pharm. (1995) 125:185-193.
   Web of Science ®Google Scholar
• NAKAMICHI K, YASUURA H, FUKUI H, OKA M, IZUMI S: Evaluation of a floating dosage form of nicardipine hydrochloride and hydroxypropylmethylcellulose acetate succinate prepared using a twin-screw extruder. Int. J. Pharm. (2001) 218:103-112.
   PubMed Web of Science ®Google Scholar
• STREUBEL A, SIEPMANN J, BODMEIER R: Floating matrix tablets based on low density foam powder: effects of formulation and processing parameters on drug release. Eur. J. Pharm. Sci. (2003) 18:37-45.
   PubMed Web of Science ®Google Scholar
• STREUBEL A, SIEPMANN J, BODMEIER R: Floating microparticles based on low density foam powder. Int. J. Pharm. (2002) 241:279-292.
   PubMed Web of Science ®Google Scholar
• STREUBEL A, SIEPMANN J, BODMEIER R: Multiple unit gastroretentive drug delivery systems: a new preparation method for low density microparticles. J. Microencapsul. (2003) 20:329-347.
   PubMed Web of Science ®Google Scholar
• DESAI S, BOLTON S: A floating controlled-release drug delivery system: in vitro-in vivo evaluation. Pharm. Res. (1993) 10:1321-1325.
   PubMed Web of Science ®Google Scholar
• KRÖGEL I, BODMEIER R: Development of a multifunctional matrix drug delivery system surrounded by an impermeable cylinder. J. Control. Release (1999) 61:43-50.
   PubMed Web of Science ®Google Scholar
• STREUBEL A: Oral Delivery Systems with Modified Drug Release. Ph.D. Thesis (2002).
   Google Scholar
• KAWASHIMA Y, NIWA T, TAKEUCHI H, HINO T, ITO Y: Preparation of multiple unit hollow microspheres (microballoons) with acrylic resin containing tranilast and their drug release characteristics (in vitro) and floating behavior (in vivo). J. Control. Release (1991) 16:279-290.
   Web of Science ®Google Scholar
• KAWASHIMA Y, NIWA T, TAKEUCHI H, HINO T, ITO Y: Hollow microspheres for use as a floating controlled drug delivery system in the stomach. J. Pharm. Sci. (1992) 81:135-140.
   PubMed Web of Science ®Google Scholar
• SATO Y, KAWASHIMA Y, TAKEUCHI H, YAMAMOTO H: Physicochemical properties to determine the buoyancy of hollow microspheres (microballoons) prepared by the emulsion solvent diffusion method. Eur. J. Pharm. Biopharm. (2003) 55:297-304.
   PubMed Web of Science ®Google Scholar
• LEE JH, PARK TG, CHOI HK: Development of oral drug delivery system using floating microspheres. J. Microencapsul. (1999) 16:715-729.
   PubMed Web of Science ®Google Scholar
• LEE JH, PARK TG, LEE YB, SHIN SC, CHOI HK: Effect of adding non-volatile oil as a core material for the floating microspheres prepared by emulsion solvent diffusion method. J. Microencapsul. (2001) 18:65-75.
   PubMed Web of Science ®Google Scholar
• EL-KAMEL AH, SOKAR MS, AL GAMAL SS, NAGGAR VF: Preparation and evaluation of ketoprofen floating oral delivery system. Int. J. Pharm. (2001) 220:13-21.
   PubMed Web of Science ®Google Scholar
• SATO Y, KAWASHIMA Y, TAKEUCHI H, YAMAMOTO H: In vitro evaluation of floating and drug releasing behaviors of hollow microspheres (microballoons) prepared by the emulsion solvent diffusion method. Eur. J. Pharm. Biopharm. (2004) 57:235-243.
   PubMed Web of Science ®Google Scholar
• SATO Y, KAWASHIMA Y, TAKEUCHI H, YAMAMOTO H, FUJIBAYASHI Y: Pharmacoscintigraphic evaluation of riboflavin-containing microballoons for a floating controlled drug delivery system in healthy humans. J. Control. Release (2004) 98:75-85.
   PubMed Web of Science ®Google Scholar
• SATO Y, KAWASHIMA Y, TAKEUCHI H, YAMAMOTO H: In vitro and in vivo evaluation of riboflavin-containing microballoons for a floating controlled drug delivery system in healthy humans. Int. J. Pharm. (2004) 275:97-107.
   PubMed Web of Science ®Google Scholar
• STITHIT S, CHEN W, PRICE JC: Development and characterization of buoyant theophylline microspheres with near zero order release kinetics. J. Microencapsul. (1998) 15:725-737.
   PubMed Web of Science ®Google Scholar
• THANOO BC, SUNNY MC, JAYAKRISHNAN A: Oral sustained-release drug delivery systems using polycarbonate microspheres capable of floating on the gastric fluid. J. Pharm. Pharmacol. (1993) 45:21-24.
   PubMed Web of Science ®Google Scholar
• JOSEPH NJ, LAKSHMI S, JAYAKRISHNAN A: A floating-type oral dosage form for piroxicam based on hollow polycarbonate microspheres: in vitro and in vivo evaluation in rabbits. J. Control. Release (2002) 79:71-79.
   PubMed Web of Science ®Google Scholar
• IANNUCCELLI V, COPPI G, BERNABEI MT, CAMERONI R: Air compartment multiple-unit system for prolonged gastric residence. Part I. Formulation study. Int. J. Pharm. (1998) 174:47-54.
   Web of Science ®Google Scholar
• IANNUCCELLI V, COPPI G, SANSONE R, FEROLLA G: Air compartment multiple-unit system for prolonged gastric residence. Part II. In vivo evaluation. Int. J. Pharm. (1998) 174:55-62.
   Web of Science ®Google Scholar
• IANNUCCELLI V, COPPI G, LEO E, FONTANA F, BERNABEI MT: PVP solid dispersions for the controlled release of furosemide from a floating multiple-unit system. Drug Dev. Ind. Pharm. (2000) 26:595-603.
   PubMed Web of Science ®Google Scholar
• IANNUCCELLI V, COPPI G, SERGI S, BERNABEI MT: Effect of the feeding conditions on the urinary excretion of riboflavin dosed by a multiparticulate floating system. Proceedings of the 4th World Meeting ADRITELF/APGI/APV. Florence, Italy (2002):551-552.
   Google Scholar
• BULGARELLI E, FORNI F, BERNABEI MT: Effect of matrix composition and process conditions on casein-gelatin beads floating properties. Int. J. Pharm. (2000) 198:157-165.
   PubMedGoogle Scholar
• TALUKDER R, FASSIHI R: Gastroretentive delivery systems: hollow beads. Drug Dev. Ind. Pharm. (2004) 30:405-412.
   PubMed Web of Science ®Google Scholar
• DOROZYNSKI P, JACHOWICZ R, KULINOWSKI P et al.: The macromolecular polymers for the preparation of hydrodynamically balanced systems – methods of evaluation. Drug Dev. Ind. Pharm. (2004) 30:947-957.
   PubMed Web of Science ®Google Scholar
• BAUMGARTNER S, KRISTL J, VRECER F, VODOPIVEC P, ZORKO B: Optimisation of floating matrix tablets and evaluation of their gastric residence time. Int. J. Pharm. (2000) 195:125-135.
   PubMed Web of Science ®Google Scholar
• COLOMBO P, PROVASI D, BORAZZO MG, MAGGI L, CATELLANI PL: The role of compression force in floating tablet formula optimization. Acta Pharm. Technol. (1989) 35:168-170.
   Web of Science ®Google Scholar
• GEROGIANNIS VS, REKKAS DM, DALLAS PP, CHOULIS NH: Floating and swelling characteristics of various excipients used in controlled release technology. Drug Dev. Ind. Pharm. (1993) 19:1061-1081.
   Web of Science ®Google Scholar
• ROUGE N, COLE ET, DOELKER E, BURI P: Screening of potentially floating excipients for minitablets. STP Pharma Sci. (1997) 7:386-392.
   Google Scholar
• BAUMGARTNER S, SMID-KORBAR J, VRECER F, KRISTL J: Physical and technological parameters influencing floating properties of matrix tablets based on cellulose ethers. STP Pharma Sci. (1998) 8:285-290.
   Google Scholar
• ROUGE N, LEROUX JC, COLE ET, DOELKER E, BURI P: Prevention of the sticking tendency of floating minitablets filled into hard gelatin capsules. Eur. J. Pharm. Biopharm. (1997) 43:165-171.
   Web of Science ®Google Scholar
• KUMAR M K, SHAH MH, KETKAR A, MAHADIK KR, PARADKAR A: Effect of drug solubility and different excipients on floating behaviour and release from glyceryl monooleate matrices. Int. J. Pharm. (2004) 272:151-160.
   PubMed Web of Science ®Google Scholar
• INGANI HM, TIMMERMANS J, MOËS AJ: Conception and in vivo investigation of peroral sustained release floating dosage forms with enhanced gastrointestinal transit. Int. J. Pharm. (1987) 35:157-164.
   Web of Science ®Google Scholar
• YANG L, FASSIHI R: Zero-order release kinetics from a self-correcting floatable asymmetric configuration drug delivery system. J. Pharm. Sci. (1996) 85:170-173.
   PubMed Web of Science ®Google Scholar
• YANG L, ESHRAGHI J, FASSIHI R: A new intragastric delivery system for the treatment of Helicobacter pylori associated gastric ulcer: in vitro evaluation. J. Control. Release (1999) 57:215-222.
   PubMed Web of Science ®Google Scholar
• LI S, LIN S, DAGGY BP, MIRCHANDANI HL, CHIEN YW: Effect of HPMC and Carbopol on the release and floating properties of Gastric Floating Drug Delivery System using factorial design. Int. J. Pharm. (2003) 253:13-22.
   PubMed Web of Science ®Google Scholar
• TIMMERMANS J, MOËS AJ: Measuring the resultant-weight of an immersed test material: I. Validation of an apparatus and a method dedicated to pharmaceutical applications. Acta Pharm. Technol. (1990) 36:171-175.
   Web of Science ®Google Scholar
• TIMMERMANS J, MOËS AJ: Measuring the resultant-weight of an immersed test material: II. Examples of kinetic determinations applied to monolithic dosage forms. Acta Pharm. Technol. (1990) 36:176-180.
   Web of Science ®Google Scholar
• TIMMERMANS J, MOËS AJ: How well do floating dosage forms float? Int. J. Pharm. (1990) 62:207-216.
   Web of Science ®Google Scholar
• ROUGE N, COLE ET, DOELKER E, BURI P: Buoyancy and drug release patterns of floating minitablets containing piretanide and atenolol as model drugs. Pharm. Dev. Technol. (1998) 3:73-84.
   PubMedGoogle Scholar
• ICHIKAWA M, WATANABE S, MIYAKE Y: A new multiple-unit oral floating dosage system. I: Preparation and in vitro evaluation of floating and sustained-release characteristics. J. Pharm. Sci. (1991) 80:1062-1066.
   PubMed Web of Science ®Google Scholar
• ATYABI F, SHARMA HL, MOHAMMAD HA, FELL JT: Controlled drug release from coated floating ion exchange resin beads. J. Control. Release (1996) 42:25-28.
   Web of Science ®Google Scholar
• ATYABI F, SHARMA HL, MOHAMMAD HA, FELL JT: In vivo evaluation of a novel gastric retentive formulation based on ion exchange resins. J. Control. Release (1996) 42:105-113.
   Web of Science ®Google Scholar
• TALUKDER R, FASSIHI R: Gastroretentive delivery systems: a mini review. Drug Dev. Ind. Pharm. (2004) 30:1019-1028.
   PubMed Web of Science ®Google Scholar
• SINGH BN, KIM KH: Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J. Control. Release (2000) 63:235-259.
   PubMed Web of Science ®Google Scholar
• NUR AO, ZHANG JS: Captopril floating and/or bioadhesive tablets: design and release kinetics. Drug Dev. Ind. Pharm. (2000) 26:965-969.
   PubMed Web of Science ®Google Scholar
• PEREZ-MARCOS B, FORD JL, AMSTRONG DJ, ELLIOTT PN, ROSTRON C, HOGAN JE: Release of propranolol hydrochloride from matrix tablets containing hydroxypropylmethylcellulose K4M and Carbopol 974. Int. J. Pharm. (1994) 111:251-259.
   Web of Science ®Google Scholar
• PEREZ-MARCOS B, FORD JL, ARMSTRONG DJ, ELLIOTT PN, ROSTRON C, HOGAN JE: Influence of pH on the release of propranolol hydrochloride from matrices containing hydroxypropylmethylcellulose K4M and Carbopol 974. J. Pharm. Sci. (1996) 85:330-334.
   PubMed Web of Science ®Google Scholar
• JIMÉNEZ-CASTELLANOS MR, ZIA H, RHODES CT: Design and testing in vitro of a bioadhesive and floating drug delivery system for oral application. Int. J. Pharm. (1994) 105:65-70.
   Web of Science ®Google Scholar